Matrixome
Matrixome is a venture company out of Osaka University, and behind the patented laminin E8 substrate, iMatrix™, and the next-generation ECM substrate, perLAM™. Our unique, patented pre-mix method allows for culturing without pre-coating, thus greatly reducing manufacturing costs, enabling easier automation, and improving proliferation.
Already globally employed in numerous clinical trials, and trusted by leading therapeutic and pharmaceutical companies, the clinical grade, PMDA approved iMatrix products are ones you can trust in your clinical manufacturing.
